Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.

Finall AI, McIntosh SA, Thompson WD.

BMJ. 2006 Dec 23;333(7582):1293-4. No abstract available.

2.

Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).

Gorter RW, van Wely M, Stoss M, Wollina U.

Am J Ther. 1998 May;5(3):181-7.

PMID:
10099057
7.

Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".

Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B.

Forsch Komplementarmed Klass Naturheilkd. 2004 Aug;11 Suppl 1:23-9.

PMID:
15353899
8.

[Added to conventional therapy, what does mistletoe extract contribute in breast carcinoma].

[No authors listed]

MMW Fortschr Med. 2004 Mar 25;146(13):58. German. No abstract available.

PMID:
15219134
9.

[Blood and tissue eosinophilia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe therapy].

Kröz M, Schad F, Matthes B, Pickartz H, Girke M.

Forsch Komplementarmed Klass Naturheilkd. 2002 Jun;9(3):160-7. German.

PMID:
12119512
10.

[Development of lymphocyte subsets in tumor patients after subcutaneous administration of mistletoe extracts].

Büssing A, Rosenberger A, Stumpf C, Schietzel M.

Forsch Komplementarmed. 1999 Aug;6(4):196-204. German.

PMID:
10529579
11.

Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.

Stein G, Henn W, von Laue H, Berg P.

Eur J Med Res. 1998 Apr 8;3(4):194-202.

PMID:
9533928
12.

[Favourable course of persisting malignant ascites].

Stange R, Jänsch A, Schrag S, Pflugbeil C, Schlodder D, Pandey-Hoffmann U, Uehleke B.

Forsch Komplementmed. 2009 Feb;16(1):49-53. doi: 10.1159/000191067. German.

PMID:
19295230
14.

Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.

Rostock M, Huber R.

Forsch Komplementarmed Klass Naturheilkd. 2004 Aug;11 Suppl 1:18-22.

PMID:
15353898
15.

[Subcutaneous manifestations of a centrocytic non-Hodgkin lymphoma at the injection site of a mistletoe preparation].

Hagenah W, Dörges I, Gafumbegete E, Wagner T.

Dtsch Med Wochenschr. 1998 Aug 21;123(34-35):1001-4. German.

PMID:
9739765
16.

Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.).

Hutt N, Kopferschmitt-Kubler M, Cabalion J, Purohit A, Alt M, Pauli G.

Allergol Immunopathol (Madr). 2001 Sep-Oct;29(5):201-3. Review.

PMID:
11720654
17.

Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.

Eisenbraun J, Scheer R, Kröz M, Schad F, Huber R.

Phytomedicine. 2011 Jan 15;18(2-3):151-7. doi: 10.1016/j.phymed.2010.06.013.

PMID:
20724129
18.

Contact sensitization by alternative topical medicaments containing plant extracts. The Dutch Contact Dermatoses Group.

Bruynzeel DP, van Ketel WG, Young E, van Joost T, Smeenk G.

Contact Dermatitis. 1992 Oct;27(4):278-9. No abstract available.

PMID:
1451514
19.

Two cases of nicorandil-induced ulceration mimicking skin malignancy.

Sharma A, Orpin S, Goulding JM, Kaur MR.

Br J Dermatol. 2014 Sep;171(3):662-3. doi: 10.1111/bjd.12978. No abstract available. Erratum in: Br J Dermatol. 2015 Jan;172(1):308. Goulding, J [corrected to Goulding, J M R]; Kaur, M [corrected to Kaur, M R].

PMID:
24836355
20.

[A case of masked sanguinaria candensis].

Schmutz JL, Trechot P.

Ann Dermatol Venereol. 2012 Jun;139(6-7):501. doi: 10.1016/j.annder.2012.04.158. French. No abstract available.

PMID:
22721485
Items per page

Supplemental Content

Support Center